Jean Nappi to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications Jean Nappi has written about Platelet Aggregation Inhibitors.
Connection Strength
0.710
-
Barriers to clopidogrel adherence following placement of drug-eluting stents. Ann Pharmacother. 2009 Feb; 43(2):259-67.
Score: 0.264
-
Benefits and limitations of current antiplatelet therapies. Am J Health Syst Pharm. 2008 Jul 01; 65(13 Suppl 5):S5-10; quiz S16-8.
Score: 0.253
-
Vorapaxar in atherosclerotic disease management. Ann Pharmacother. 2015 May; 49(5):599-606.
Score: 0.100
-
Combination antiplatelet therapy: implications for pharmacists. J Am Pharm Assoc (Wash). 2002 Nov-Dec; 42(6):880-3.
Score: 0.043
-
New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Ann Pharmacother. 2001 May; 35(5):589-617.
Score: 0.039
-
Glycoprotein IIb/IIIa receptor inhibitors in percutaneous coronary intervention and acute coronary syndrome. Ann Pharmacother. 2003 Jun; 37(6):860-75.
Score: 0.011